Journal article
Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort
Abstract
INTRODUCTION: Many women at risk of fracture do not receive anti-osteoporosis medication (AOM), while others may be receiving unnecessary treatment.
PURPOSE: To examine the characteristics associated with AOM use among women at low and high risks of fracture.
Authors
Guggina P; Flahive J; Hooven FH; Watts NB; Siris ES; Silverman S; Roux C; Pfeilschifter J; Greenspan SL; Díez-Pérez A
Journal
Bone, Vol. 51, No. 6, pp. 975–980
Publisher
Elsevier
Publication Date
12 2012
DOI
10.1016/j.bone.2012.08.130
ISSN
8756-3282